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ABSTRACT
Objectives: Multimorbidity is the presence of 2 or
more medical conditions. This increasingly used
assessment has not been assessed in a surgical
population. The objectives of this study were to assess
the prevalence of multimorbidity and its association
with common outcome measures.
Design: A cross-sectional observational study.
Setting: A UK-based multicentre study, included
participants between July and October 2014.
Participants: Consecutive emergency (non-elective)
general surgical patients admitted to hospital, aged
over 65 years.
Outcome measures: The outcome measures were
(1) the prevalence of multimorbidity and (2) the
association between multimorbidity and frailty; the rate
and severity of surgery; length of hospital stay;
readmission to hospital within 30 days of discharge;
and death at 30 and 90 days.
Results: Data were collected on 413 participants aged
65–98 years (median 77 years, (IQR (70–84)). 51.6%
(212/413) participants were women. Multimorbidity
was present in 74% (95% CI 69.7% to 78.2%) of the
population and increased with age (p<0.0001).
Multimorbidity was associated with increasing frailty
(p for trend <0.0001). People with multimorbidity
underwent surgery as often as those without
multimorbidity, including major surgery (p=0.03).
When comparing multimorbid people with those
without multimorbidity, we found no association
between length of hospital stay (median 5 days, IQR
(1–54), vs 6 days (1–47), (p=0.66)), readmission to
hospital (64 (21.1%) vs 18 (16.8%) (p=0.35)), death
at 30 days (14 (4.6%) vs 6 (5.6%) (p=0.68)) or 90-day
mortality (28 (9.2%) vs 8 (7.6%) (p=0.60)).
Conclusions and implications: Multimorbidity is
common. Nearly three-quarters of this older
emergency general surgical population had 2 or more
chronic medical conditions. It was strongly associated
with age and frailty, and was not a barrier to surgical
intervention. Multimorbidity showed no associations
across a range of outcome measures, as it is currently
defined. Multimorbidity should not be relied on as a
useful clinical tool in guidelines or policies for older
emergency surgical patients.
INTRODUCTION
Multimorbidity is deﬁned as the coexistence
of two or more chronic medical conditions
in one individual. In developed countries,
approximately one-quarter of adults can be
deﬁned as multimorbid,1 2 and more than
half of older Americans possess three or
more chronic illnesses.3 Multimorbidity
reﬂects the complex interplay between mul-
tiple diseases and includes both physical and
mental health conditions.4 It is indicative of
the fact that as opposed to participants in
the clinical trial (from whom evidence is
usually derived), older patients in clinical
practice rarely present acutely with a single
pathology.5 Additionally, as one would expect,
where multimorbidity is observed, polyphar-
macy often coexists due to medical manage-
ment of chronic diseases. This iatrogenic
component of managing several coexistent
diseases coupled with polypharmacy is also
thought to amplify the complexities encoun-
tered in managing such patients.
Many studies detail comorbidity in nearly
all branches of medicine,6 however, the
Strengths and limitations of this study
▪ We found multimorbidity to be very common
when defined simplistically as two or more
chronic conditions.
▪ In a large multicentre observational setting, the
study did not demonstrate any associations
between adverse outcome and multimorbidity.
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speciﬁc concept of multimorbidity (two or more path-
ologies) is still novel in medicine. Few studies exist that
characterise multimorbidity in all patient populations,1 3
and no such studies have been conducted in surgical
populations. Therefore, if we are to provide better care
for such high-risk patients, there is a need for data that
are both representative and contemporary of older
patients admitted as surgical emergencies.
The primary aims of this study were to assess the
prevalence of multimorbidity in a large representative
UK-wide sample population of patients admitted to sec-
ondary care with emergency general surgical problems,
and measure the amount of polypharmacy present.
Secondary aims included: assessment of whether multi-
morbidity was associated with outcome; prevalence and
severity of surgical intervention; rate of hospital readmis-
sion within 30 days of discharge; length of hospital stay;
and death at 30 and 90 days following index admission.
METHODS
An established surgical research collaboration (http://
www.opsoc.eu) collected data across ﬁve sites within the
UK: one in Wales, two in Scotland and two in England.
Cardiff, Bristol and Aberdeen sites are large teaching
hospitals, which serve urban and rural communities.
The Manchester site is an inner city teaching hospital,
and the Glasgow site a District General Hospital situated
in Greater Glasgow. We studied consecutive patients
aged 65 years and over admitted to respective emer-
gency general surgical admissions units over a 4-month
period from July to October 2014.
At each site, data collectors were trained in the study
protocol and standard operating procedures. All data
were collated using password-protected, prepopulated
Microsoft Excel spreadsheets. All patient-identiﬁable
data were removed, handled and stored according to
local data management guidelines. Data were captured
using intranet systems, scrutiny of patient case notes and
prescribing charts. We obtained relevant institutional
approvals at respective sites. Since this study examined
information that is currently collected as part of routine
care, it was deemed to be service evaluation and, as
such, did not require external ethical approval.
Outcome measures
The primary outcome was to estimate the prevalence of
multimorbidity. Secondary outcomes measures were the
association between multimorbidity and: frailty (mea-
sured using the 7-point Canadian Study of Health and
Ageing (CSHA) scale); the rate and severity of surgery;
length of hospital stay; readmission to hospital within
30 days of discharge; and death at 30 and 90 days.
Multimorbidity was deﬁned as the coexistence of two
or more chronic diseases. There is no existing formally
agreed deﬁnition of which conditions should be consid-
ered as contributing towards the diagnosis. However, we
based our predeﬁned inclusion criteria on the most
common conditions identiﬁed from an inclusive system-
atic review published by Diederichs et al.7 This review
identiﬁed the most common conditions listed in con-
temporary studies in multimorbidity. The Charlson
index is a broad, widely used and well-established tool
used to measure comorbidity in clinical practice.8 To
ensure that our deﬁnition of multimorbidity reﬂected a
broad range of conditions we identiﬁed 18 conditions
between this index and the systematic review by
Diederichs et al. These are listed in ﬁgure 1.
Within 24 h of admission and prior to any surgical inter-
vention, patients’ multimorbidity status was assessed from
admission medical records. We assessed and recorded
baseline demographic and physiological data: age group
(65–74, 75–84 and ≥85 years) and gender. Haemoglobin
concentration (≤129 g/L classiﬁed as anaemia), serum
albumin (≤35 g/L classiﬁed as low) and the number of
current medications (<5 or ≥5) were also recorded.
Polypharmacy was deﬁned as more than, or equal to ﬁve
oral or inhaled medications. To assess frailty we used an
established and well-validated seven-point clinical frailty
score derived from the CSHA.9 This simple scale estimates
an individual’s level of frailty through visual observation in
combination with an abbreviated review of their current
medical records. The seven grades of frailty are: very ﬁt,
well, well with treated comorbidities, apparently vulner-
able, mildly frail, moderately frail and severely frail.
We recorded whether each person underwent a surgi-
cal procedure. The severity of surgery was graded using
the ﬁve-point BUPA severity of surgery score.10 This
score divides the severity of surgery into minor, intermedi-
ate, major, major plus and complex major. For purposes
of data analysis, we grouped the severity of surgery;
minor/intermediate surgeries and major/above surgeries.
Data were also collected on length of stay (recorded as
whole-day integers, with any part of a day rounded
upward), readmission to the index hospital (regardless of
the readmission diagnosis) within 30 days of discharge
from the index surgical admission and death within both
30 days and 90 days of the index admission.
Statistical analysis
Cross-sectional tabulations of categorical variables were
tested using a χ2 test of association, and a Wilcoxon rank
Figure 1 Conditions used to define multimorbidity.
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test for non-normally distributed continuous variables.
The following were determined by the literature as pre-
conceived scientiﬁcally justiﬁed explanatory covariates:
sex, age, anaemia, low albumin and polypharmacy.
Independent scientiﬁcally justiﬁed covariates were ﬁtted
as predictors using an unadjusted logistic regression
model and ORs with 95% CIs presented. A ﬁnal parsi-
monious multivariable logistic model was derived using
a forward stepping regression model by including any
covariate that exhibited statistical signiﬁcance (p<0.05)
in any of the three univariable analyses. All statistical cal-
culations were conducted using STATAV.13 (Stata Corp).
RESULTS
Data were collected on 413 participants. Two had insufﬁ-
cient data recorded and were excluded from the data
analysis. Therefore, 411 participants were included in the
analysis; 92 people in Wales (Cardiff), 128 in England
(51 in Manchester and 77 in Bristol) and 191 in Scotland
(45 in Glasgow and 146 in Aberdeen). The median age
was 77 years (IQR 70–84). The study cohort included 212
(51.6%) women and 199 (48.4%) men, who did not
differ in age distribution (p=0.36). Seventy-four per cent
of participants (304/411) were classiﬁed as multimorbid
(95% CI 69.7% to 78.2%). The prevalence of multimor-
bidity was associated with increasing age (p<0.0001) but
not gender (p=0.62) (table 1). The prevalence of multi-
morbidity did not differ between study sites with a range
of 68.6% in Manchester to 80.5% in Bristol (p=0.61).
There were 183 (44.5%) people who met the deﬁn-
ition of anaemia. Of those participants with multimor-
bidity, 146 (48.0%) were anaemic compared with 37
(34.6%) of the non-multimorbid group (p=0.02). Low
serum albumin was recorded in 171 (41.6%) of the
population. Hypoalbuminaemia was more common in
those with multimorbidity (45%) (p=0.02). Polypharmacy
was recorded in 279 participants (67.9%), and was more
common in the multimorbid group (78.9%) compared
with the non-multimorbid group (36.4%) (p<0.0001).
For the whole population, the seven-point frailty scale
showed 73 (17.9%) of patients were ﬁt, 52 (12.8%) well,
89 (21.8%) well with treated comorbid conditions, 81
(19.8%) apparently vulnerable, 56 (13.7%) mildly frail,
41 (10.1%) moderately frail and 16 (3.9%) severely frail
(data were not available for 3 patients for this variable).
Nearly 28% of all participants were mildly frail or above.
Increasing frailty was associated with multimorbidity (p
for trend <0.0001).
In total, 79 (19.2%) people underwent a surgical pro-
cedure. The number of participants undergoing surgical
intervention did not differ between the groups (55,
(18.1%) of the multimorbid group versus 24 (22.4%) of
the non-multimorbid group, p=0.33). Category of
surgery was unrecorded for nine participants. Of those
who underwent surgery, 46 (65.7%) were coded as
major or above in severity. More major surgeries were
conducted in the multimorbid group with 42 (91.3%)
procedures occurring in this group compared with 17
(70.8%) minor/intermediate procedures (p=0.03). All
results are listed in table 2.
The median length of stay (LOS) (or time spent in
hospital until death) was 5½ days (range 1–90 days, IQR
1–72 days). Eleven people had missing data for LOS.
The average LOS was 5 days (1–47) in the multimorbid
group versus, 6 days (1–54) in the non-morbid group
(p=0.66). Eighty-two patients were readmitted to hospital
within 30 days of discharge. Of these, 64 had multimorbid-
ity. When compared with the 18 without multimorbidity,
there was no difference in the incidence of readmission
(p=0.35). Twenty participants (4.9%) died within 30 days,
and 36 participants (8.8%) died within 90 days of hospital
admission. There was no statistically signiﬁcant difference
in 30-day or 90-day mortality between the multimorbid
and non-multimorbid groups (p=0.68 and 0.60, respect-
ively). Full results are shown in table 2.
The unadjusted ORs for death within 30 and 90 days
for those with multimorbidity were 0.81 (95% CI 0.30 to
2.17, p=0.60) and 1.24 (95% CI 0.58 to 2.80, p=0.68)
respectively, and 1.31 (95% CI 0.74 to 2.34) for readmis-
sion (table 3).
Univariate analysis between readmission and haemoglo-
bin, albumin, polypharmacy, frailty (grouped as mildly
frail or worse) and operation (yes or no) are shown in
table 3. Albumin, polypharmacy and frailty were asso-
ciated with the outcomes of interest, and were included
in all the ﬁnal multivariate models. The adjusted OR
(aOR) between death at 30 days and multimorbidity was
0.94 (95% CI 0.49 to 1.78; p=0.84) after adjustment for
albumin, polypharmacy and frailty. The aOR for death at
Table 1 Prevalence of multimorbidity, with age and sex
Overall
Multimorbidity
p ValueYes No
Number (%) 411 (100) 304 (74.0) 107 (26.0)
Age, years (IQR) 77 (70–84) 78 (72–85) 72 (65–89) <0.0001
Aged 65–74 years (%) 169 (41.1) 106 (62.7) 63 (37.3) <0.0001
75–84 years 150 (36.5) 121 (80.7) 29 (19.3)
Over 85 years 92 (22.4) 77 (83.7) 15 (16.3)
Women (%) 212 (51.6) 53 (25.0) 159 (75.0) 0.62
Men (%) 199 (48.4) 54 (27.1) 145 (72.9)
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90 days and readmission to hospital were 0.83 (95% CI
0.33 to 2.08; p=0.69) and 0.94 (95% CI 0.49 to 1.78;
0.84), respectively.
DISCUSSION
This is the ﬁrst study in a surgical population assessing
multimorbidity, indicating its prevalence and correlation
with outcome in an emergency (non-elective) setting.
We identiﬁed multimorbidity (deﬁned as two or more
chronic diseases) in 74% of our population. The popula-
tion was also shown to be frail. We did not ﬁnd any asso-
ciation between multimorbidity and length of hospital
stay, hospital readmission or death.
We have shown that 83.7% of our population aged
over 85 years, and 62.7% aged 65–74 years have multi-
morbidity. There are no directly comparable studies of
general surgical patients (or any other surgical subspeci-
alty) with which to compare and contrast our ﬁndings.
However, there are studies that have assessed the
prevalence of multimorbidity in other areas of medicine.
These studies commonly use information derived from
existing databases in different population groups. In
2012, Barnett et al1 conducted an analysis of Scottish
primary care health records in 1 750 000 people of all
ages. They identiﬁed multimorbidity in 23.2% of the
study population. In those aged 65–84 years, the ﬁgure
was 64.9% increasing to 81.5% in those aged 85 years
and over. A recent community-based representative Swiss
study of 3714 people estimated the prevalence of multi-
morbidity to be 56.3% in people aged 35–75 years, but
found the ﬁgure to be much lower in people who self-
reported multimorbidity.11 In the 63 people aged over
65 years who had multimorbidity objectively measured,
they found multimorbidity to have a prevalence of 70%.
This is similar to rates of multimorbidity identiﬁed in
our patients group.
Unsurprisingly, as anaemia and hypoalbuminaemia are
markers of poor health following surgical intervention,12 13
our multimorbid population had a high prevalence of
Table 2 Characterisation of the multimorbid and non-multimorbid populations
Overall
Multimorbidity
p ValueYes (%) No
Number (%) 411 304 (74.0) 107 (26.0)
Haemoglobin (≤129 g/L) 183 (44.5) 146 (79.8) 37 (20.2 0.02
Albumin, (≤35 g/L) 171 (41.6) 137 (80.1) 34 (19.9) 0.02
Polypharmacy (yes %) 279 (67.9) 240 (86.0) 39 (14.0) <0.0001
Frailty (Canadian Study of Health and Ageing scale)
Very fit 73 (17.9) 32 (43.8) 41 (56.2) <0.0001
Well 52 (12.8) 28 (53.8) 24 (46.2) Test for trend
Well, with comorbidity 89 (21.8) 72 (80.9) 17 (19.1)
Apparently vulnerable 81 (19.8) 65 (80.2) 16 (19.8)
Mildly frail 56 (13.7) 49 (87.5) 7 (12.5)
Moderately frail 41 (10.1) 39 (95.1) 2 (14.9)
Severely frail 16 (3.9) 16 (100) 0
Operation (yes %) 79 (19.2) 55 (69.6) 24 (30.4) 0.33
Minor or intermediate surgery 24 (34.3) 7 (29.2) 17 (70.8) 0.03
Major or more severe surgery 46 (65.7) 41 (91.3) 4 (8.7)
Missing 9
Length of hospital stay (days, 95% CI) 9.3 (8.1 to 10.5) 9.1 (7.5 to 10.4) 9.8 (7.2 to 12.5) 0.29
Readmission to hospital (yes %) 82 (19.9) 64 (78.0) 18 (22.0) 0.35
Death within 30 days (yes %) 20 (4.9) 14 (70.0) 6 (30.0) 0.68
Death within 90 days (yes %) 36 (8.8) 28 (77.8) 8 (22.2) 0.60
Table 3 Univariable logistic regression for death at 30 days, 90 days and readmission
Unadjusted OR for
death at 30 days, (95%
CI), p value
Unadjusted OR for death
at 90 days, (95% CI),
p value
Unadjusted OR for
readmission, (95% CI),
p value
Multimorbidity 0.81 (0.30 to 2.17), 0.68 1.24 (0.55 to 2.81), 0.60 1.31 (0.74 to 2.34), 0.35
Haemoglobin (≤129 g/L) 1.56 (0.63 to 3.84), 0.33 1.83 (0.92 to 3.67), 0.09 1.58 (0.97 to 2.57), 0.06
Albumin, (≤35 g/L) 2.74 (1.07 to 7.02), 0.04 3.09 (1.50 to 6.37), 0.002 1.27 (0.78 to 2.07), 0.33
Polypharmacy (yes %) 1.44 (0.51 to 4.05), 0.49 1.24 (0.58 to 2.66), 0.58 1.88 (1.07 to 3.33), 0.03
Mildly frail or worse 2.77 (1.11 to 6.84), 0.03 3.29 (1.64 to 6.60), 0.001 1.81 (1.08 to 3.02), 0.02
Operation (yes %) 1.03 (0.33 to 3.16), 0.96 1.04 (0.44 to 2.48), 0.93 1.46 (0.82 to 2.61), 0.19
Main effects included in the adjusted multivariable model are in bold.
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both. A commonly used marker of comorbidity is poly-
pharmacy, as the majority of people with several coexist-
ing medical conditions will be taking medications. Again
we found a strong association between polypharmacy
and multimorbidity. As multimorbidity and its impact on
health are due, in part, to the interactions between
health and medication, future studies would beneﬁt
from reviewing types of medications and dosages with
respect to outcomes in multiple morbid surgical
patients.
This study reports the ﬁrst ﬁndings with regard to the
relationships between multimorbidity, the choice of con-
servative versus emergency surgical intervention and
complexity of surgery. Our ﬁndings demonstrated that
multimorbidity does not appear to be a barrier to emer-
gency surgery, and that the emergency surgical proce-
dures that these patients underwent were of a more
complex nature. Primary malignancy and metastases
contribute to both the diagnosis of multimorbidity and
emergency general surgical workload. Additionally,
conditions such as autoimmune disease or peripheral
vascular disease (which are classed as multimorbid con-
ditions) are associated with other common emergency
general surgical conditions (eg, mesenteric ischaemia).
Hence our ﬁndings regarding the rate and type of
surgery are likely to be simply reﬂective of the typical
emergency general surgical patients observed during the
study period, and as such, may represent confounding.
Therefore, less inference should be drawn when compar-
ing our ﬁndings with elective general surgical patients.
Our results did not identify any association between
multimorbidity and our selected outcome measures.
Multimorbidity is not a barrier to emergency surgical
intervention, which can be viewed positively by an
increasingly aged and multimorbid population. It is pos-
sible that a longer follow-up period, or alternative
outcome measures, such as postoperative complications,
would have identiﬁed a positive correlation. However, our
results did show that multimorbidity was strongly asso-
ciated with frailty which is, in turn, associated with poor
outcome in surgical populations,14–17 including emer-
gency general surgery.18 This ﬁnding has been consistent
across a range of frailty measures and populations. Future
studies should directly compare multimorbidity and frailty
in order to assess which is a better predictive measure in
the assessment of the older elective and emergency surgi-
cal patient.
This study was designed as part of a larger epidemio-
logical project to collect comprehensive data sets of
older surgical patients undergoing emergency surgical
intervention. Multimorbidity was one of our chosen
exploratory areas of study. We would have expected to
detect some sign of true association (positive or other-
wise) in a population of this size. However, the study did
not start with predetermined power calculations to test
outcome associations between multimorbidity and out-
comes. Nonetheless, a sample of over 400 participants
represents a pragmatic data gathering operation, and to
detect no signal regarding the use of multimorbidity
alone implies that multimorbidity is not, and is unlikely
to become, a useful predictor of outcome in the emer-
gency general surgical patient.
Future studies should, therefore, focus on more
sophisticated estimation of multimorbidity. The most
simplistic approach would be to simply increase the
number of conditions needed to deﬁne multimorbidity.
Koller et al19 showed that three conditions taken together
predicted a higher level of care provision after several
years of follow-up in a large German cohort. Alternatively,
the effect of multimorbidity could be stratiﬁed by certain
conditions, for example, hypertension or diabetes, which
for the majority of those affected, these common condi-
tions are treated and well controlled. It is also likely that
future deﬁnitions of multimorbidity will become more
sophisticated in other ways, for example, to include only
active or untreated disease. Based on our ﬁndings, we
would recommend future research in this area to explore
a range of inclusion criteria when considering how to
deﬁne and further characterise the multimorbid, emer-
gency general surgical population. Our study has also
demonstrated that polypharmacy is prevalent and a more
detailed medication study of drug numbers and classes is
warranted. It may also be appropriate for future studies,
particularly those considering an intervention, to con-
sider where clinical input may be useful for example,
pharmacist review of medication or physician review prior
to surgery.
More detailed epidemiological data, for example,
socioeconomic status, would allow a more accurate
picture of the nature and generalisability of future data.
In addition, as data were collected over summer and
autumn, it is possible that the data recorded would have
differed in the winter months. Additional comorbidity
and increased winter pressures on hospital systems may
have substantially affected our results and is a consider-
ation for future studies. Although we did not detect a
difference between the prevalence of multimorbidity
across our ﬁve different sites, another potential bias is
interobserver and site variability. All the sites and obser-
vers were trained in the use of the study standard operat-
ing procedures, and all data were collected via a
prepopulated form and collated by the lead author.
However, it is possible that different observers systematic-
ally assessed patient multimorbidity differently, and this
should also be noted. Nevertheless, the data collected
were mainly objective data, and ﬁxed at the time of
assessment (eg, age, list of medications, mortality data,
etc), and hence, the possibility of bias introduced by
interobserver differences is minimal. Future large-scale
studies should also ensure that centralised multimorbid-
ity and frailty training is part of the study protocol, in an
attempt to minimise this limitation.
Despite our study limitations, data were collected in
ﬁve different sites; Cardiff (Wales), Manchester and
Bristol (England), Glasgow and Aberdeen (Scotland)
spread widely across the whole of mainland UK. These
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sites include urban and rural populations, and both aca-
demic and non-academic institutions. Additionally, other
markers of generalisability, such as the prevalence of
frailty, which we measured as 27.7% (mildly frail or
worse), were consistent with what we would expect in a
UK older emergency surgical population.20 As such, we
feel that our population is representative of the UK
population.
In conclusion, the results from this large, UK-wide rep-
resentative sample are the ﬁrst description of multimor-
bidity in an emergency surgical population. We have
demonstrated that multimorbidity is highly prevalent;
with nearly three-quarters of emergency general surgical
patients aged over 65 years having two or more medical
conditions. Those with multimorbidity underwent
complex surgical procedures more frequently than those
without multimorbidity. However, we did not detect any
correlations between multimorbidity and a range of
commonly used outcome measures. This study used the
standard deﬁnition of multimorbidity, namely two condi-
tions. We would advocate that future studies of this
nature consider more sophisticated deﬁnitions of multi-
morbidity, and a threshold level for the number of con-
ditions affecting outcome should be explored.
Alternatively, by deﬁning deﬁnitions of active or quies-
cent chronic disease more precisely, or with a greater
focus on attendant polypharmacy, better predictive
models of multimorbidity could be identiﬁed. We would
also encourage that multimorbidity be compared to
other methods of estimating ill health in older people,
such as frailty.
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